Vident Investment Advisory, LLC - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 68 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Vident Investment Advisory, LLC ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2020$1,063,000
-24.4%
133,240
-5.2%
0.05%
-28.4%
Q2 2020$1,406,000
+13.0%
140,529
-51.4%
0.07%
+10.4%
Q1 2019$1,244,000
-27.6%
289,340
-3.2%
0.07%
-30.2%
Q4 2018$1,718,000
-34.1%
298,850
+55.4%
0.10%
-5.9%
Q3 2018$2,607,000
+6.8%
192,251
-6.5%
0.10%
+5.2%
Q2 2018$2,442,000
-14.9%
205,701
-11.1%
0.10%
-17.1%
Q1 2018$2,870,000
+153.5%
231,349
+36.6%
0.12%
+129.4%
Q4 2017$1,132,000
-45.0%
169,406
-32.5%
0.05%
-54.1%
Q3 2017$2,057,000
+88.2%
251,145
+3.1%
0.11%
+23.3%
Q2 2017$1,093,000
-14.7%
243,535
+4.7%
0.09%
-29.1%
Q1 2017$1,282,000
+63.3%
232,641
+20.0%
0.13%
+33.7%
Q4 2016$785,000
+52.1%
193,869
+165.0%
0.10%
+37.7%
Q3 2016$516,000
-14.0%
73,145
-0.6%
0.07%
-17.9%
Q2 2016$600,000
-47.7%
73,572
-47.9%
0.08%
+18.3%
Q1 2016$1,148,000
+26.0%
141,086
+86.8%
0.07%
-38.3%
Q4 2015$911,00075,5400.12%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q3 2017
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 1,377,294$2,341,0003.33%
Matrix Capital Management Company, LP 38,974,185$66,256,0001.50%
NEA Management Company, LLC 17,082,612$29,040,0001.49%
Endurant Capital Management LP 1,824,065$3,101,0001.09%
Long Focus Capital Management, LLC 4,679,491$7,955,0000.83%
Key Client Fiduciary Advisors, LLC 416,166$707,0000.69%
PFM Health Sciences, LP 9,109,780$15,487,0000.59%
ACT CAPITAL MANAGEMENT, LLC 90,000$153,0000.21%
DAFNA Capital Management LLC 351,064$597,0000.16%
Rock Springs Capital Management LP 2,357,544$4,008,0000.12%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders